RecruitingNCT05577689

Novel Therapy Target in Metastatic Prostate Cancer

Combining Multi-omics Analysis and Organoid Models to Search for Novel Therapy Target in Metastatic Prostate Cancer


Sponsor

Fudan University

Enrollment

100 participants

Start Date

Aug 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to use multiomics sequencing to explore the molecular characteristics of metastatic prostate cancer (mPCa), especially metastatic castration-resistant prostate cancer (mCRPC). At the same time, mCRPC models will be constructed, including organoids and animal models, serving as a basic and translational research platform to help identify novel drug targets for mPCa.


Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting tumor samples from men with metastatic prostate cancer to study new therapy targets. Researchers hope to identify specific proteins or molecules in the tumor that could be targeted by future treatments. **You may be eligible if...** - You have been diagnosed with prostate cancer confirmed by biopsy - Your cancer has spread to other parts of the body (metastatic disease) - You are scheduled for or able to undergo surgery or a biopsy to provide a tumor sample - You can provide informed consent **You may NOT be eligible if...** - You have been diagnosed with another type of cancer in addition to prostate cancer - A tumor sample cannot be safely obtained - You cannot provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTissue

Tissue will be derived from patients during a standard of care procedure


Locations(1)

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05577689


Related Trials